1-4 of 4
Eva Bandres
Close
Sort by
Journal Articles

Monitoring Early CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation By Pentamer and Streptamer Staining

Lorea Beloki, Miriam Ciaurriz, Natalia Ramirez, Amaya Zabalza, Cristina Mansilla, Eva Bandres, Mercedes Rodriguez Calvillo, Eduardo Olavarría
Journal: Blood
Blood (2013) 122 (21): 4597.
https://doi.org/10.1182/blood.V122.21.4597.4597
Published: 2013
Journal Articles

SETBP1 overexpression is a novel leukemogenic mechanism that predicts adverse outcome in elderly patients with acute myeloid leukemia

Ion Cristóbal, Francisco J. Blanco, Laura Garcia-Orti, Nerea Marcotegui, Carmen Vicente, José Rifon, Francisco J. Novo, Eva Bandres, María J. Calasanz, Carmelo Bernabeu, María D. Odero
Journal: Blood
Blood (2010) 115 (3): 615–625.
https://doi.org/10.1182/blood-2009-06-227363
Published: 2010
Includes: Supplemental data
Journal Articles

GATA2 Is Overexpressed in 46% of Patients with AML and Normal Karyotype. The Mutational Pattern FLT3-ITD/GATA2/WT1 Could Define a Group of Patients with Normal Karyotype and AML-M1 Subtype.

Idoya Lahortiga, PhD, Iria Vazquez, BSc, Nerea Marcotegui, BSc, Eva Bandres, PhD, Raquel Malumbres, PhD, Maria J. Larrayoz, BSc, Carmen Vicente, BSc, Jose Cervera, MD, PhD, Jesus M. Hernandez, MD, PhD, Jesus Garcia-Foncillas, MD, PhD, Maria T. Ardanaz, MD, Filomena Floristan, MD, Maria J. Calasanz, PhD, Maria D. Odero, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2378.
https://doi.org/10.1182/blood.V106.11.2378.2378
Published: 2005
Journal Articles

A Gain of Function Mutation in JAK2 Is Frequently Found in Patients with AML-M2 and Normal Karyotype.

Nerea Marcotegui, BSc, Idoya Lahortiga, PhD, Iria Vazquez, BSc, Jose L. Vizmanos, PhD, Ion Cristobal, BSc, Cristina Ormazabal, BSc, Eva Bandres, PhD, Maria J. Larrayoz, BSc, Carmen Vicente, BSc, Maria J. Calasanz, PhD, María D. Odero, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2366.
https://doi.org/10.1182/blood.V106.11.2366.2366
Published: 2005